P-DL1
Showing 1 - 25 of >10,000
Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)
Enrolling by invitation
- Autism Spectrum Disorder
- +6 more
- SRS 2, CBCL, BRIEF-P
-
Penrith, New South Wales, Australia
- +57 more
Sep 18, 2022
MDD With Anxious Distress Trial in Worldwide (JNJ-61393215, Placebo)
Completed
- Major Depressive Disorder With Anxious Distress
- JNJ-61393215
- Placebo
-
Garden Grove, California
- +34 more
Sep 2, 2022
Developmental Endothelial Locus-1, Platelet Count, and Soluble
Not yet recruiting
- Overweight and Obesity
- Platelet count
- +2 more
-
Aswan, EgyptAswan University Hospital
May 17, 2023
Prevalence of Hyperandrogenism in Type 1 Diabetes
Recruiting
- Type 1 Diabetes
- +5 more
- Clinical hyperandrogenism assessment
- +20 more
-
Madrid, SpainHospital Universitario Ramón y Cajal
Mar 14, 2022
Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)
Completed
- Immune System Disorder (Healthy Volunteers)
- Belumosudil
- +3 more
-
Miami, FloridaInvestigational Site Number: 8400001
Apr 11, 2023
Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal
Not yet recruiting
- Esophagus Cancer
- +4 more
- Intravenous injection of P-IL-2
- P-IL-2 plus Anti-PD-1 Monoclonal Antibody
- (no location specified)
Apr 24, 2023
Gout, CKD Stage 1-4, SUA Level (>8 mg/dL; 480 µmol/L) Trial in Kiev (Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral
Enrolling by invitation
- Gout
- +2 more
- Febuxostat 80 MG Oral Tablet or Allopurinol 300 MG Oral Tablet
-
Kiev, UkraineMedical Practice Prof D.Ivanov
Aug 22, 2022
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- P-CD19CD20-ALLO1
- Rimiducid
-
La Jolla, California
- +7 more
Aug 25, 2023
Alzheimer Trial in Worldwide (neflamapimod, )
High Blood Sugar, Metabolic Syndrome Trial (ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules)
Not yet recruiting
- High Blood Sugar
- Metabolic Syndrome
- ANKASCIN 568-P Red yeast rice capsules
- Placebo Capsules
- (no location specified)
Feb 10, 2023
CS1P1 PET Studies of Neuroinflammation in Parkinson Disease
Not yet recruiting
- Parkinson Disease
-
Saint Louis, MissouriWashington University School of Medicine
Oct 10, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Visual Perception Difficulties After Stroke
Recruiting
- Stroke
- Visual Perception
- OxVPS
-
Abingdon, United Kingdom
- +2 more
Jul 31, 2023
Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T
Recruiting
- Breast Cancer
- +8 more
- P-MUC1C-ALLO1 CAR-T cells
- Rimiducid
-
San Francisco, California
- +4 more
Oct 26, 2022
Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))
Recruiting
- Bladder Carcinoma in Situ (CIS)
- ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
-
New Orleans, LouisianaOchsner Clinic Foundation
Jan 18, 2023
Metastatic Colorectal Cancer Trial in Austin (Fruquintinib, Dabigatran Etexilate, Rosuvastatin)
Completed
- Metastatic Colorectal Cancer
- Fruquintinib
- +2 more
-
Austin, TexasPPD Development
Oct 5, 2022
Type 1 Diabetes Trial in Mainz, Neuss (M1 Pram P037, Insulin lispro)
Completed
- Type 1 Diabetes Mellitus
- M1 Pram P037
- Insulin lispro
-
Mainz, Germany
- +1 more
Jun 23, 2022
Mental Health Wellness 1 Trial in Pontypridd (Immediate Appointment, Delayed Appointment)
Withdrawn
- Mental Health Wellness 1
- Immediate Appointment
- Delayed Appointment
-
Pontypridd, United KingdomUniversity of South Wales
Feb 24, 2022
Type2Diabetes, Severe Mental Disorder Trial in London
Recruiting
- Type2Diabetes
- Severe Mental Disorder
-
London, United Kingdom
- +8 more
Jul 11, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- 1.1 GBq (30 mCi) of 177Lu-P17-087
- 1.1 GBq (30 mCi) of 177Lu-P17-088
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 30, 2022
Hypertension, Dyslipidemia Trial in Canada, United Kingdom (Amlodipine/Atorvastatin)
Completed
- Hypertension
- Dyslipidemia
-
Calgary, Alberta, Canada
- +125 more
Jan 26, 2021